Search research articles
Contact Us
Filters
Showing results (291-300 of 335) with videos related to
Page
of 34
Sort By:
Hippocampus
|
April 11, 2017
The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals
Daniel Ferreira, Oskar Hansson, José Barroso, et al.
Annals of Neurology
|
January 23, 2014
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing
Christopher C Rowe, Pierrick Bourgeat, Kathryn A Ellis, et al.
Brain : a Journal of Neurology
|
July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease
Gaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms
James D Doecke, Alan Rembach, Victor L Villemagne, et al.
Alzheimer'S Research & Therapy
|
November 20, 2015
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
Alan Rembach, Lisbeth A Evered, Qiao-Xin Li, et al.
Nature Communications
|
November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease
Kevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
International Journal of Epidemiology
|
March 9, 2018
Genome-wide average DNA methylation is determined in utero
Shuai Li, Ee Ming Wong, Pierre-Antoine Dugué, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Qiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology
|
July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer disease
James D Doecke, Simon M Laws, Noel G Faux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
Alan Rembach, Noel G Faux, Andrew D Watt, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 335) with videos related to
Sort By:
Page
of 34
Hippocampus
|
April 11, 2017
The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals
Daniel Ferreira, Oskar Hansson, José Barroso, et al.
Annals of Neurology
|
January 23, 2014
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing
Christopher C Rowe, Pierrick Bourgeat, Kathryn A Ellis, et al.
Brain : a Journal of Neurology
|
July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease
Gaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms
James D Doecke, Alan Rembach, Victor L Villemagne, et al.
Alzheimer'S Research & Therapy
|
November 20, 2015
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
Alan Rembach, Lisbeth A Evered, Qiao-Xin Li, et al.
Nature Communications
|
November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease
Kevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
International Journal of Epidemiology
|
March 9, 2018
Genome-wide average DNA methylation is determined in utero
Shuai Li, Ee Ming Wong, Pierre-Antoine Dugué, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Qiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology
|
July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer disease
James D Doecke, Simon M Laws, Noel G Faux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
Alan Rembach, Noel G Faux, Andrew D Watt, et al.
Page
of 34